WE BELIEVE the future of image analysis is dependent on products that deliver new information that seamlessly integrates into existing protocols without changing patterns of operational norms. We are leading this belief through product innovation, pioneering talent, and a commitment to simplicity of use.

Management Team

Thomas E. (“Tom”) Ramsay - Founder, Chairman and CEO, Imago Systems, Inc.

Thomas E. (“Tom”) Ramsay

Founder, Chairman, and CEO, Imago Systems, Inc.

John Leger

Chief Operating Officer,
Imago Systems, Inc.

John Boney

VP Business Development, PetViewDX, LLC

Scott Hallihan

Director, PetViewDX, LLC

Karen Morgan, Ph.D.

Director of Product Development and Engineering

Gene Ramsay

Director of Research

Nancy Goetzinger

Director of Training

Members of the Board

Susan Alpert, M.D., PH.D. - Member of the Board of Directors

Susan Alpert, M.D., Ph.D.

Board of Directors

Mark Libratore - Member of the Board of Directors

Mark Libratore

Board of Directors

Jeannette McGill Corbett - Member of the Board of Directors

Jeannette McGill Corbett

Board of Directors

Medical Advisory Board

Patrick Griffith - headshot

Patrick K. Griffith, M.D., FACS, MBA

Medical Advisory Board,
Thoracic - Cardiology

Santosh Kesari - headshot

Santosh Kesari, M.D., Ph.D.

Medical Advisory Board, Neurology - Oncology

Sanjay Bhojraj - headshot

Sanjay Bhojraj, M.D.

Medical Advisory Board, Cardiovascular Medicine

Tom Martyak, M.D.

Medical Advisory Board, Cardiovascular Medicine

Pat Basu, M.D. - headshot

Pat A. Basu, M.D., MBA

Imago Business and Clinical Advisor

Patricia Cole - Headshot

Patricia Cole, M.D., Ph.D.

Medical Advisory Board, Radiology - Cardiology - Oncology

Business Consultant Team

Bret Williams

Corporate Advisor,
Vestech Securities, Inc.

J. Peter McBride - headshot

J. Peter McBride

Imago Cardiovascular and Strategic Business Advisor

Thomas E. (“Tom”) Ramsay - Founder, Chairman and CEO, Imago Systems, Inc.

Thomas E. (“Tom”) Ramsay

Founder, Chairman, and CEO, Imago Systems, Inc.

Tom Ramsay is an imaging expert with more than 40 years of experience, including numerous breakthroughs in the development of technologies for a wide range of applications. Tom holds 10 patents, either granted or pending, in the domains of optics, image processing, and computer-based machine learning.

Tom is a nationally recognized imaging expert, consulting on a wide range of scientific projects for U.S.-based and global companies, including Pioneer, Sony, Matsushita, NEC, Hitachi, 3M Corporation, American College of Radiology, Radiological Society of North America, American Society of Clinical Pathologists, CDC (Asia), United Nations, Lockheed, Northrop Grumman, U.S. Department of Homeland Security, and Thomson CSF (France).

Tom’s experience also includes several senior level positions, including managing projects for Sony, NEC, Hitachi, Pioneer, and others. He has invented a wide range of technologies for image processing, optical disk recording, and the radiology community, including co-invention of the first PACS (picture archiving and communications system) for breast imaging while serving as CEO of Image PSL—an innovator in image processing and medical training in partnership with the Mayo Clinic and Yale Medical School.

Tom’s background also includes several startups organized around his inventions, including the development of technologies to create a national product imaging database for Japan; photo microscopy analysis of tuberculosis in Africa; image-based gem trading in Thailand; explosive detection through analysis of X-ray images generated by portable bomb technician systems and through analysis of images generated by X-ray scanners of carry-on luggage moving through TSA airport checkpoints; fingerprint optimization analysis for the FBI; and the restoration of Thomas Edison’s movies for the Library of Congress in Washington, D.C.

In 2013, Tom was honored with an Alumnus of Notable Achievement Award from the University of Minnesota for his contributions in medicine and image processing. He also served as a member of the Emerging Technologies Advisory Group (EmTAG), a select advisory panel of the Association for Information and Image Management (AIIM).

Tom holds a Bachelor of Arts from the University of Minnesota.

John Leger

Chief Operating Officer,
Imago Systems, Inc.

Bio coming soon.

John Boney

VP Business Development, PetViewDX, LLC

Bio coming soon.

Scott Hallihan

Director, PetViewDX, LLC

Bio coming soon.

Karen Morgan, Ph.D.

Director of Product Development and Engineering

Karen is responsible primarily for transitioning new technology applications from research into products. During her four years with Imago, Karen’s work has focused on product and software development in the Human Imaging space, including for Breast and Cardiovascular imaging. These efforts range from product definition and testing to implementation of processes necessary for FDA guidance-compliant development practices.

Karen brings many years of experience in medical imaging device development in both small start-up environments and at multinational corporations Siemens and Analogic. Prior to joining Imago, Karen worked for more than a dozen years to bring an ultrasound imaging technology from university research to an FDA-approved medical device. As a member of that startup team, she was responsible for overseeing multiple government-funded research grants and contracts, as well as general product management. As the technology was proven, she helped develop Quality Management and Software Development Processes at the small business level and eventually merged these processes with those of the corporation that acquired the technology to bring the device to market. Following FDA approval, Karen was responsible for both the technical development and project management of new features for the product.

Karen holds a Bachelor of Science in Physics and a Ph.D. in Biomedical Engineering from the University of Virginia. The focus of her doctoral training was image and digital signal processing.

Gene Ramsay

Director of Research

Gene is an expert in the fields of image science and multimedia with a successful career in inventing, developing, and distributing imaging technologies, applications, and products to solve complex issues in imaging and machine learning for artificial intelligence (AI) applications. He has developed an interdisciplinary research approach to focus on new image processing and analysis technologies aimed at better differentiating organic and inorganic objects within an image. As an imaging consultant, Gene completed a wide range of scientific projects for national and global customers, including Pioneer, Sony, Matsushita, NEC, Hitachi, 3M Corporation, United Nations, Lockheed, Northrop Grumman, U.S. Department of Homeland Security, U.S. Library of Congress, American College of Radiology, Radiological Society of North America, American Society of Clinical Pathologists, Mayo Clinic, Harvard, Yale, and Thomson CSF (France).

Gene’s experience also includes senior management positions and inventing a wide range of technologies for image processing, machine learning, image restoration, optical recording, Homeland Security systems, and the telecommunications industry. He has a strong passion for strategic thinking and the evolution of creative problem solving to benefit humanity.

Gene currently has ten patents granted for inventions in high-speed optical disk recording, optical systems, and digital image processing and analysis, with additional patents pending.

Gene holds a Bachelor of Science from the University of Minnesota.

Nancy Goetzinger

Director of Training

Bio coming soon.

Susan Alpert, M.D., PH.D. - Member of the Board of Directors

Susan Alpert, M.D., Ph.D.

Board of Directors

Susan is Principal of SFA Regulatory, LLC, a consultancy to companies placing products into the U.S. healthcare market. Prior to SFA, Susan spent 8 years at Medtronic, where she served in many roles, including Senior Vice President of Global Regulatory Affairs from November 2005 to May 2011. At Medtronic, Susan was responsible for the company’s quality, regulatory, and clinical compliance efforts, including overseeing health policy and payment.

Prior to joining Medtronic, Susan served as Vice President of Regulatory Sciences at C.R. Bard Inc. Before joining Bard, Susan served at the FDA where she held a variety of positions in the Centers dealing with drugs, devices and radiological health, and foods, including six years as the Director of the Office of Device Evaluation.

Susan has served on the board of the Food and Drug Law Institute (FDLI), was a Director of the Medical Technology Leadership Forum (MTLF), and a Director of the Women Business Leaders (WBL), and is the immediate past chair of the board of the Society for Women’s Health Research (SWHR). She is a microbiologist and pediatrician with a specialty in infectious diseases and has practical experience in laboratory research and clinical trials.

Susan holds an M.S. and Ph.D. in Biomedical Sciences (Microbiology) from New York University. She received her M.D. from the University of Miami and completed her clinical training at Montefiore Medical Center in New York and at Children’s National Medical Center in Washington, DC. She completed her undergraduate degree at Barnard College, Columbia University.

Mark Libratore - Member of the Board of Directors

Mark Libratore

Board of Directors

Mark has over 30 years of healthcare experience, and is the founder and former CEO of Liberation LLC, a Florida Corporation. He also serves as a consultant to, and investor in, several private and public companies. From 2007 to 2016, Mark founded and served as CEO and President of Liberator Medical Holdings, Inc. (LBMH, NYSE), which was acquired by C.R. Bard.

Mark founded Liberty Medical Supply Inc. in 1990 and served as its President and Chief Executive Officer. He sold the company to PolyMedica Corporation (PLMD, NYSE) in August 1996, and remained as President of Liberty Medical and Vice President of PolyMedica until February 1999.

Prior to Liberty Medical Supply, Mark founded Action Medical Supply, Inc., which was the basis for Liberator Medical Holdings. Before that, at the early stage of the rapidly growing home medical care industry, Mark started a successful home medical equipment company, Ambassador Inhalation and Respiratory Services Inc., which grew to multiple locations in Florida and was acquired by Foster Medical.

Earlier in his career, Mark worked at several Hospitals in Connecticut and Florida, including founding the Cardiopulmonary Dept. at Jupiter Hospital as its Director.

Mark has served multiple terms on the Palm Beach Board of the American Lung Association, Hospice of Martin, and various other associations. The April 1998 issue of Response Magazine voted Mark as one of the top 25 most innovative direct TV advertisers of the year, and in 2010, he was the recipient of the Florida Governor’s Business Diversification award in business expansion.

Mark is a graduate from the Hartford Hospital School of Allied Health’s Respiratory Certification Program, and has held or been responsible for licenses in clinical laboratory technology, respiratory therapy, diabetes education, pharmacy, and cardiopulmonary technology in Florida and state licenses for Home Medical Supply in 36 states.

Jeannette McGill Corbett - Member of the Board of Directors

Jeannette McGill Corbett

Board of Directors

Jeannette is a Certified Public Accountant and is currently Chair of the Finance Committee, lifetime Board Member, and President Emeritus of the Quantum Foundation, the largest health funder in Palm Beach County, Florida. Jeannette also serves on the Board of Directors of the Nicklaus Children’s Health Care Foundation. Previously, she served as CFO of the Medical Services Division and Vice President of Finance of Phymatrix Corporation (PHMX), West Palm Beach, Florida. Prior to her position at Phymatrix, Mrs. Corbett was President of McGill, Roselli, Ayala & Hoppmann, a West Palm Beach-based accounting firm. She has also served as an adjunct instructor of taxation at Palm Beach State College in Lake Worth, Florida. Mrs. Corbett has a Bachelor of Science degree in Business Administration from the University of Florida, graduating Summa Cum Laude, and a Master Degree from Palm Beach Atlantic College. Mrs. Corbett was Chairman of the Board of JFK Medical Center in Atlantis, Florida, from 1991-1994 and was Chair of the Hospital’s Finance Committee from 1989-1991.

Patrick Griffith - headshot

Patrick K. Griffith, M.D., FACS, MBA

Medical Advisory Board,
Thoracic - Cardiology

Patrick Griffith, M.D., FACS, MBA, is a Cardiothoracic Surgeon with 25 years of experience performing over 5,500 complex open-heart operations. Major focus is currently on ascending aortic and root pathology while advancing skills in minimally invasive and structural heart operations, complex mitral valve and coronary operations.

EXPERIENCE
April 2020 – Present: Adventist Heart and Vascular Institute – Maryville, California
February 2017 – April 2020: MEDICAL DIRECTOR, Thoracic Surgery, Salinas Valley Healthcare System – Salinas, California
2003-2017: CHIEF OF CARDIAC SURGERY, Rideout Medical Center – Marysville, California
1998-2003: STAFF CARDIOVASCULAR & THORACIC SURGEON, Kettering Cardiothoracic & Vascular Surgeons – Kettering, Ohio
1997-1998: STAFF CARDIOVASCULAR & THORACIC SURGEON, Cardiothoracic & Vascular Surgeons – Lima, Ohio
1996-1997: CARDIOTHORACIC SURGEON, Holmes Regional Medical Center – Melbourne, Florida

POSTGRADUATE TRAINING
2011-2013: EXECUTIVE MBA, University of California Irvine – Irvine, California
1995-1996: PEDIATRIC CARDIAC SURGERY, Egleston Hospital of Emory University – Atlanta, Georgia
1992-1995: CARDIOTHORACIC SURGERY RESIDENT, University of North Carolina – Chapel Hill, North Carolina
1990-1992: GENERAL SURGERY SENIOR/CHIEF RESIDENT, Georgetown University – Washington, DC
1988-1990: CARDIAC SURGERY FELLOW, National Heart, Lung & Blood Institute – Bethesda, MD
1985-1988: GENERAL SURGERY INTERN/JUNIOR RESIDENT, West Virginia University – Morgantown, West Virginia

MEDICAL SCHOOL
1981-1985: UNDERGRADUATE (Graduated with Honors), Washington University – St. Louis, Missouri

UNDERGRADUATE
1977-1981: Northwestern University Evanston, Illinois, Graduated with Honors

HONORS

  • National Merit Semi-Finalist – 1976
  • Honors Medical School Performance – 1984, 1985
  • Chief Resident of the Year – 1992
  • Resident Teacher of the Year – 1992
  • Outstanding Physician of the Year – 2004
  • Healthgrades 5-star rating Valve Replacement Surgery – 2008
  • Beta Gamma Sigma Business Honor Society – 2013
  • Best Team Player – UCI Business School – 2013
Santosh Kesari - headshot

Santosh Kesari, M.D., Ph.D.

Medical Advisory Board, Neurology - Oncology

Dr. Santosh Kesari is a board-certified neurologist and neuro-oncologist and is currently Chair and Professor, Department of Translational Neurosciences and Neurotherapeutics, Saint John’s Cancer Institute. He was named regional medical director of Providence Southern California’s Research Clinical Institute in April 2021.

He is also Director of Neuro-oncology at Pacific Neuroscience Institute, Providence Saint John’s Health Center, and Providence Little Company of Mary Medical Center Torrance and leads the Pacific Neuroscience Research Center at Pacific Neuroscience Institute.

Dr. Kesari is ranked among the top 1% of neuro-oncologists and neurologists in the nation, according to Castle Connolly Medical Ltd and is an internationally recognized scientist and clinician.

He is a winner of an Innovation Award by the San Diego Business Journal. He is on the advisory board of American Brain Tumor Association, San Diego Brain Tumor Foundation, Chris Elliott Fund, Nicolas Conor Institute, Voices Against Brain Cancer, and Philippine Brain Tumor Alliance. He has been the author of over 250 scientific publications, reviews, or books.

He is the inventor on several patents and patent applications, and founder and advisor to many cancer and neurosciences focused biotech startups. In addition, he is a member of the Los Angeles Biomedical Research Institute.

Dr. Kesari has had a long-standing interest in cancer stem cells and studies their role in the formation of brain tumors and resistance to treatment. He believes that in order to cure patients with brain tumors we first need to gain a better molecular and biological understanding of the disease.

A physician/scientist, Kesari harnesses his experience in surgery, chemotherapy, immunotherapy, radiation therapy and novel devices to help develop Precision Therapeutic Strategies that will advance medicine to a new stage in the battle against brain tumors and eradicate the disease.

Highlights
Dr. Kesari graduated from University of Pennsylvania, School of Arts and Sciences in 1992 and earned a PhD degree in molecular biology and a MD from the University of Pennsylvania, School of Medicine.

He completed his residency in neurology at the Massachusetts General Hospital/Brigham and Women’s Hospital/Harvard Medical School and his neuro-oncology fellowship at the Dana-Farber Cancer Institute in Boston.

He was previously assistant professor of neurology at Harvard Medical School/Dana-Farber Cancer Institute/Brigham and Women’s Hospital and then professor of neurosciences at UC San Diego.

He is a member of the Society of Neuro-Oncology, American Society of Clinical Oncology, Indian Society of Neuro-Oncology, American Neurological Association, and American Academy of Neurology.

Sanjay Bhojraj - headshot

Sanjay Bhojraj, M.D.

Medical Advisory Board, Cardiovascular Medicine

Sanjay Bhojraj, M.D., is an interventional cardiologist at Mission Heritage Medical Group in Ladera Ranch, California. He specializes in interventional cardiology and has over 19 years of experience in the field of medicine.

EXPERIENCE
Dr. Sanjay Bhojraj, M.D., is a cardiology specialist in Mission Viejo, CA. Dr. Bhojraj completed a residency at Northwestern Center Feinberg School of Medicine. He currently practices at Mission Heritage Medical Group and is affiliated with Providence Mission Hospital, Mission Viejo. Dr. Bhojraj is board certified in Interventional Cardiology.

EDUCATION

  • Henry Ford Health System, Fellowship Hospital — 2010
  • Northwestern Center Feinberg School of Medicine, Residency Hospital — 2005
  • Northwestern Center Feinberg School of Medicine, Internship Hospital — 2003
  • Indiana University / School of Medicine, Medical School — 2002

Tom Martyak, M.D.

Medical Advisory Board, Cardiovascular Medicine

Tom Martyak, M.D., Is Board Certified in Cardiovascular Diseases and Interventional Cardiology.

EXPERIENCE
Dr. Tom Martyak, M.D., served as the cardiac cath lab director at Mary Washington Hospital for 20 plus years. He just retired from that position.

He attended Georgetown University for medical school and then entered the Army. He trained at Walter Reed Medical Center for Cardiology and Interventional Cardiology after a start in Emergency Medicine. Dr. Martyak was Chief of Cardiology at William Beaumont in El Paso, Texas.

He then relocated to Fredericksburg, Virginia, to begin the Interventional cardiology program at Mary Washington Hospital. He has extensive experience with cardiac catheterization, coronary and peripheral vascular intervention, and clinical research. He has lived and practiced in the Fredricksburg area for over 30 years.

Dr. Martyak has a special interest in educating his patients and their family members to their specific cardiac issue, so they can be involved in improving their overall cardiac health. He is currently active in working with the Imago team in preparing for a first submission to FDA for visualization in cardiology.

Pat Basu, M.D. - headshot

Pat A. Basu, M.D., MBA

Imago Business and Clinical Advisor

Pat A. Basu, MD, MBA, is a pioneering business leader, entrepreneur and Stanford University-trained physician who served as a senior White House advisor on then-President Obama’s economic and health agendas. Dr. Basu brings to CTCA a wealth of leadership experience gleaned from years spent in numerous senior executive positions in the business, government, clinical and not-for-profit sectors. He serves as President and Chief Executive Officer at Cancer Treatment Centers of America Global, Inc. In his role, Dr. Basu leads the strategic, operational and visionary direction of the national footprint of hospitals and outpatient care centers, in the Cancer Treatment Centers of Comprehensive Cancer Care Network, expanding patient access to the network’s signature comprehensive, personalized model of care and overseeing new business initiatives designed to enhance the delivery of high-quality, evidence-based oncology care. As a member of the CTCA National Board of Directors, he collaborates with other mission-driven visionaries to identify and deliver new, innovative therapies to heal the whole person, improve quality of life and restore hope for both patients and their caregivers.

Most recently, as a Partner at the private equity firm Chicago Pacific Founders and venture capital firm Pritzker Group Venture Capital, he led investments for entrepreneurs and high-growth companies innovating the delivery of health care, specifically in the areas of health technology, value-based payment and senior care. Previously, Dr. Basu served as a Senior Vice President and member of the Executive Leadership Team of UnitedHealth Group, a Fortune 10 company. Among his key responsibilities, he served as President of OptumCare, the largest physician group and value-based care business in the United States with more than 20,000 clinicians delivering care to millions of Medicare Advantage and commercially insured Americans in pay-for-performance models.

Prior to Optum/UnitedHealth, guided by a keen sense for the needs of consumers, especially patients, Dr. Basu co-founded Doctor on Demand, helping launch the delivery of telemedicine, then in its infancy, into the homes of millions of Americans. Under his leadership Doctor on Demand became the largest provider of telehealth video visits in the United States. Dr. Basu also served as President, Chief Operating Officer and Board Director of vRad (a merger of the publicly traded firms Nighthawk and Virtual Radiologic), helping the company grow into the largest provider of radiology services in the United States while delivering high-quality, timely care to over 8 million Americans through partnerships with more than 2,500 hospitals, employers and physician groups.

He’s put the breadth of his expertise and passion for leadership to work for others while serving on the advisory boards of Walgreens, General Electric, CareCredit, Takeda, McKinsey & Co. and the American Medical Association. He’s also served as a senior advisor or consultant for several Fortune 500 firms, private equity firms and hospital systems.

Outside his official duties, Dr. Basu dedicates much of his time to community and public-service leadership roles. A board-certified radiologist with expertise in treating cancer patients, Dr. Basu continues to provide care to U.S. veterans at the VA Hospital System. He’s served as member of The Council on Foreign Relations, the US-Japan Foundation, Atlantik-Brücke US-Germany, the Illinois State Board of Health, the Illinois Institute of Government & Public Affairs, Leadership Greater Chicago, the Economic Club of Chicago and as a Regional Commissioner of the White House Fellows. He’s also served on the Board of Directors for the University of Illinois and the Stanford University Medical Alumni Association and has delivered keynote addresses at over 150 corporations, universities, governments and professional societies. National news networks—including CBS, NBC, WGN, Fox and NPR—have sought his expert commentary on numerous topics over the years, and seven major universities have invited him to offer his expertise as visiting faculty.

Dr. Basu completed his medical training at Stanford University and went on to serve as Chief Resident at Stanford University Medical Center before completing Stanford Business School’s Faculty Leadership Program. As Founding Faculty Director of Health Policy and Finance, in addition to his clinical and administrative duties, he taught Stanford medical and business students. In 2010, he took a leave of absence from Stanford to serve as a White House Fellow and Senior Advisor, serving at the highest levels of federal government while helping to execute portions of President Obama’s economic and health agenda.

Dr. Basu is a recipient of the American Medical Association’s National Excellence Award for Leadership, Stanford Medicine’s Specialist Physician of the Year Award, the Crain’s Chicago Business 40 Under 40 Award, The Governor Edgar Fellowship and the Daniel Burnham Fellowship of Leadership Greater Chicago. He is the recipient of the Distinguished Alumni Award from the University of Illinois where he received his Bachelor’s Degree in Mechanical Engineering and the Distinguished Alumni Award from the University of Chicago Booth School of Business where he received his Master’s in Business Administration (MBA).

Patricia Cole - Headshot

Patricia Cole, M.D., Ph.D.

Medical Advisory Board, Radiology - Cardiology - Oncology

Patricia E. Cole, Ph.D., M.D., is Executive Director and Head of the Imaging Strategy Group in the Oncology Strategic Business Unit at Bayer Pharmaceuticals where she is responsible for the imaging biomarker component of oncology drug development plans and for the oversight of imaging biomarkers in oncology clinical trials.

Dr. Cole has had over 20 years of experience in the pharma industry with a focus on biomarkers in clinical trials. She has utilized x-ray, CT, MRI, MR spectroscopy, PET, SPECT, photography, ultrasound and DXA imaging modalities and includes deep learning and radiomics tools in image analysis approaches. Her therapeutic area experience includes CNS, oncology, hematology, cardiovascular, metabolism, diabetes, obesity, arthritis, immunology, inflammation and pulmonology.

Her positions have included:

  • Clinical Director at Novartis, initially in Experimental Clinical Development and then in Biomarker Development; Senior Director and Global Head of Imaging Biomarkers at Eisai Medical Research.
  • Vice President and Head of Imaging Core Lab at ImagePace, LLC.
  • CEO of Cole Imaging and Biomarker Consulting, LLC.
  • Medical Fellow in the Translational Imaging Group, Tailored Therapeutics, Eli Lilly and Company.

Prior to joining Bayer, she served as Executive Director, Translational Research and Early Clinical Imaging at Takeda Pharmaceuticals.

Dr. Cole has also been an active participant in precompetitive space consortia and working groups involving:

  • The advancement of quantitative imaging biomarkers including the Innovative Medicines Initiative in Immune Cell Imaging.
  • Quantitative Imaging Biomarker Alliance (QIBA) where she is a member of the Steering Committee, a member of the Multiparametric Imaging Biomarker Metrology committee and serves as co-chair of the Magnetic Resonance Elastography Biomarker Committee.
  • Alzheimer’s Disease Neuroimaging Initiative (ADNI), for which she served as an Industry Scientific Advisory Board chair, and the Coalition Against Major Diseases (CAMD) where she was involved in qualification of imaging biomarkers for subject enrichment in prodromal AD and in early Parkinson’s Disease trials.

Dr. Cole is a board-certified radiologist with subspecialty qualification in cardiovascular and
interventional radiology. She completed her M.D. degree at Albert Einstein College of Medicine and held an American Cancer Society Special Postdoctoral Fellowship during medical school.

Her radiology residency and fellowship were completed at NY Hospital-Cornell Medical Center. Her radiology faculty positions included Memorial Sloan Kettering Cancer Center and Yale-New Haven Medical Center.

Dr Cole also holds a Ph.D., in biophysical chemistry and after a postdoctoral fellowship in molecular biology, she held faculty positions in the Department of Chemistry at Columbia University and in molecular Biophysics and Biochemistry at Yale.

Bret Williams

Corporate Advisor,
Vestech Securities, Inc.

Bio coming soon.

J. Peter McBride - headshot

J. Peter McBride

Imago Cardiovascular and Strategic Business Advisor

Peter has more than 40 years of healthcare experience, both nationally and Internationally, for feasibility assessment, business development, management, marketing, technology consulting, clinical operations and as a Faculty Professor at Loma Linda University.

Peter is a consultant for multiple medical manufacturers for product distribution and marketing.
Developed Feasibility Assessment and Strategies for six (6) Physician owned Heart and Vascular Institutes.

Cardiovascular Resource Solutions (CRS), Inc., is a healthcare consulting, education, investment strategist and management firm working exclusively in cardiovascular services whose clients include ambulatory surgical centers, large and small healthcare organizations, cardiovascular physician groups, manufacturers and other healthcare-related firms.

Over the last 25 years CRS has conducted more than 350 strategic consulting engagements, assisted in the development of 100 medical facilities, both nationally and internationally, founded 3 publicly traded companies and provide investment strategies for 65 healthcare start-up companies.

The CRS team has positively impacted the quality, accessibility and scope of cardiovascular care available to more than 25% of the population of the U.S. In addition to domestic clients, CRS has been retained to provide cardiovascular consulting services internationally in Halifax, Nova Scotia, Canada; City of Shanghai, People’s Republic of China; Port of Spain, Trinidad & Tobago; Republic of Cyprus; St. Croix, U.S. Virgin Islands; Dubai City, Dubai, United Arab Emirates; and the City of Culiacán, State of Sinaloa, United Mexican States.